Evidence map›Paper›PMID 34002224›Full record

ArticleMolecular biology and evolution2021

Analysis of Genomic DNA from Medieval Plague Victims Suggests Long-Term Effect of Yersinia pestis on Human Immunity Genes.

Alexander Immel, Felix M Key, András Szolek, Rodrigo Barquera, Madeline K Robinson, Genelle F Harrison, William H Palmer, Maria A Spyrou, Julian Susat, Ben Krause-Kyora and 17 more

Open access · goldAbstract read
In one paragraph

Article in Molecular biology and evolution, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Role of Killer Ig-like Receptors in Diseases from A to Z.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 3 countries.

Alexander ImmelMax Planck Institute for the Science of Human History, Jena, Germany.ORCID 0000-0002-8970-4383
Felix M KeyMax Planck Institute for the Science of Human History, Jena, Germany.ORCID 0000-0003-2812-6636
András SzolekApplied Bioinformatics, Department for Computer Science, University of Tübingen, Tübingen, Germany.
Rodrigo BarqueraMax Planck Institute for the Science of Human History, Jena, Germany.
Madeline K RobinsonDivision of Biomedical Informatics and Personalized Medicine, and Department of Immunology & Microbiology, University of Colorado, Boulder, CO, USA.
Genelle F HarrisonDivision of Biomedical Informatics and Personalized Medicine, and Department of Immunology & Microbiology, University of Colorado, Boulder, CO, USA.
William H PalmerDivision of Biomedical Informatics and Personalized Medicine, and Department of Immunology & Microbiology, University of Colorado, Boulder, CO, USA.
Maria A SpyrouMax Planck Institute for the Science of Human History, Jena, Germany.
Julian SusatInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Ben Krause-KyoraInstitute of Clinical Molecular Biology, Kiel University, Kiel, Germany.
Kirsten I BosMax Planck Institute for the Science of Human History, Jena, Germany.
Stephen ForrestInstitute of Archaeological Sciences, University of Tübingen, Tübingen, Germany.
Diana I Hernández-ZaragozaMax Planck Institute for the Science of Human History, Jena, Germany.
Jürgen SauterDKMS, Tübingen, Germany.
Ute SollochDKMS, Tübingen, Germany.
Alexander H SchmidtDKMS, Tübingen, Germany.
Verena J SchuenemannInstitute of Archaeological Sciences, University of Tübingen, Tübingen, Germany.
Ella ReiterInstitute of Archaeological Sciences, University of Tübingen, Tübingen, Germany.
Madita S KairiesInstitute for Archaeological Sciences, WG Palaeoanthropology, University of Tübingen, Tübingen, Germany.
Rainer WeißState Office for Cultural Heritage Management, Stuttgart Regional Council, Esslingen, Germany.
Susanne ArnoldState Office for Cultural Heritage Management, Stuttgart Regional Council, Esslingen, Germany.
Joachim WahlInstitute for Archaeological Sciences, WG Palaeoanthropology, University of Tübingen, Tübingen, Germany.
Jill A HollenbachUCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Oliver KohlbacherApplied Bioinformatics, Department for Computer Science, University of Tübingen, Tübingen, Germany.
Alexander HerbigMax Planck Institute for the Science of Human History, Jena, Germany.ORCID 0000-0003-1176-1166
Paul J NormanDivision of Biomedical Informatics and Personalized Medicine, and Department of Immunology & Microbiology, University of Colorado, Boulder, CO, USA.
Johannes KrauseMax Planck Institute for the Science of Human History, Jena, Germany.
Max Planck Institute for the Science of Human History · DEUniversity of Colorado Boulder · USArchäologisches Landesmuseum Baden-Württemberg · DEChristian-Albrechts-Universität zu Kiel · DEDeutsche Knochenmarkspenderdatei · DEUniversity of Tübingen · DEUniversity of Zurich · CHMax Planck Institute for Developmental Biology · DEMax Planck Institute for Evolutionary Anthropology · DEMax Planck Institute for Infection Biology · DEUniversity of California, San Francisco · US

Funding

The landscape of HLA mediated variation in health and immunityR01AI158861 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOLLENBACH, JILL ALLISON · 2021 to 2025
$3.5M
Natural Killer cells and the Immunogenetics of COVID-19R01AI158410 · NIAID · UNIVERSITY OF COLORADO DENVER · PI NORMAN, PAUL JOHN · 2021 to 2024
$2.9M
Evolution and Function of Immunogenetic Diversity Across the Eastern HemisphereR56AI151549 · NIAID · UNIVERSITY OF COLORADO DENVER · PI NORMAN, PAUL JOHN · 2020 to 2020
$387k
NIAID NIH HHS R01 AI158410NIAID NIH HHS R01 AI158861NIAID NIH HHS R56 AI151549
6 · The paper itself

Abstract

Pathogens and associated outbreaks of infectious disease exert selective pressure on human populations, and any changes in allele frequencies that result may be especially evident for genes involved in immunity. In this regard, the 1346-1353 Yersinia pestis-caused Black Death pandemic, with continued plague outbreaks spanning several hundred years, is one of the most devastating recorded in human history. To investigate the potential impact of Y. pestis on human immunity genes, we extracted DNA from 36 plague victims buried in a mass grave in Ellwangen, Germany in the 16th century. We targeted 488 immune-related genes, including HLA, using a novel in-solution hybridization capture approach. In comparison with 50 modern native inhabitants of Ellwangen, we find differences in allele frequencies for variants of the innate immunity proteins Ficolin-2 and NLRP14 at sites involved in determining specificity. We also observed that HLA-DRB1*13 is more than twice as frequent in the modern population, whereas HLA-B alleles encoding an isoleucine at position 80 (I-80+), HLA C*06:02 and HLA-DPB1 alleles encoding histidine at position 9 are half as frequent in the modern population. Simulations show that natural selection has likely driven these allele frequency changes. Thus, our data suggest that allele frequencies of HLA genes involved in innate and adaptive immunity responsible for extracellular and intracellular responses to pathogenic bacteria, such as Y. pestis, could have been affected by the historical epidemics that occurred in Europe.

Indexed as

PlagueYersinia pestisDNAGenomicsHumansPandemicsDNAaDNAancient DNAHLAhuman immunitynatural selectionplagueYersinia pestis

Identifiers

PMID34002224
PMCPMC8476174
OpenAlexW3160581690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.